Arkolith/Insider Trading/PALI/Form 4

Neal James R

DirectorPALISADE BIO, INC. (PALI) · full profile →Form 4 · filed Feb 13, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
2 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2024Option exercise(M)6K—$011K
Feb 9, 2024Option exercise(M)5K—$05K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2024Option exercise(M)7K—$07K
Feb 9, 2024Option exercise(M)5K—$00
Feb 9, 2024Option exercise(M)6K—$00
Feb 9, 2024Option exercise(M)12K—$00
Feb 9, 2024Option exercise(M)12K—$012K
Feb 9, 2024Option exercise(M)7K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-006049) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML